Sintilimab,Cisplatin,Paclitaxel,5-fluorouracil
Innovent Biologics,eli lilly
['sintilimab', 'esophageal', 'innovent']
aacr: innovent releases final analysis results of sintilimab + chemotherapy for first-line esophageal squamous cell carcinoma. indication already approved in china and included in nrdl 
'best guests ever' according to one airbnb host | senior editor & weekly recapper @endpts | Hong Konger | biopharma news? amber@endpointsnews.com